Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases

Quazim A. Alayo, Aava Khatiwada, Anish Patel, Maria Zulfiqar, Anas Gremida, Alexandra Gutierrez, Richard P. Rood, Matthew A. Ciorba, George Christophi, Parakkal Deepak*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)1698-1702
Number of pages5
JournalInflammatory Bowel Diseases
Volume27
Issue number10
DOIs
StatePublished - 1 Oct 2021
Externally publishedYes

Keywords

  • biologics
  • combination therapy
  • inflammatory bowel disease
  • tofacitinib

Fingerprint

Dive into the research topics of 'Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases'. Together they form a unique fingerprint.

Cite this